19 May 2013
Keywords: Hospira, Hydromorphone, Product recall, USA, FDA
Article | 20 August 2012
USA-based Hospira (NYSE: HSP), the world’s leading provider of injectable drugs and infusion technologies, last week initiated a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 August 2012
17 May 2013
© 2013 thepharmaletter.com